ADAR1 Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.9M | Buy |
296,766
+80,600
| +37% | +$1.06M | 0.6% | 38 |
|
|
2025
Q1 | $3.11M | Buy |
216,166
+62,139
| +40% | +$894K | 0.58% | 45 |
|
|
2024
Q4 | $2.58M | Buy |
154,027
+130,725
| +561% | +$2.19M | 0.52% | 41 |
|
|
2024
Q3 | $373K | Sell |
23,302
-229,895
| -91% | -$3.68M | 0.06% | 122 |
|
|
2024
Q2 | $2.29M | Buy |
253,197
+46,341
| +22% | +$418K | 0.43% | 36 |
|
|
2024
Q1 | $2.34M | Buy |
+206,856
| New | +$2.34M | 0.53% | 34 |
|